PEOPLE: GenomeWeb s Weekly Personnel Roundup in the Genomics Sector | GenomeWeb

NEW YORK, Nov. 7 — San Diego-based GeneFormatics on Wednesday said that it has added Edward Lanphier to its board of directors.

Lanphier, the founder, president and CEO of Sangamo BioSciences, will assist the privately-held structural proteomics firm with business development and management. 

Lanphier founded Sangamo BioSciences in 1997. Before that he was a senior executive at Somatix Therapy Corporation, vice president for corporate development at Synergen, and the former president and CEO of BioGrowth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.